These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10779344)

  • 1. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
    Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
    Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
    Gontarek RR; Derse D
    Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
    Martarano L; Stephens R; Rice N; Derse D
    J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
    Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
    J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
    Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
    J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.
    Harris ME; Gontarek RR; Derse D; Hope TJ
    Mol Cell Biol; 1998 Jul; 18(7):3889-99. PubMed ID: 9632773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
    Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
    J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characterization of Rev variation in equine infectious anemia virus.
    Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
    J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.
    Yi R; Bogerd HP; Cullen BR
    J Virol; 2002 Mar; 76(5):2036-42. PubMed ID: 11836381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
    Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
    J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.
    Umunnakwe CN; Loyd H; Cornick K; Chavez JR; Dobbs D; Carpenter S
    Retrovirology; 2014 Dec; 11():115. PubMed ID: 25533001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer.
    Asang C; Hauber I; Schaal H
    Nucleic Acids Res; 2008 Mar; 36(5):1450-63. PubMed ID: 18203748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.